98%
921
2 minutes
20
Background: Cardiogenic shock is associated with high rates of mortality in pregnancy but remains understudied.
Objectives: We aim to understand the etiologies, risk factors, and outcomes of cardiogenic shock in women of childbearing age and identify whether there are pregnancy-related differences in procedural utilization.
Methods: We analyzed all delivery, pregnancy, and cardiogenic shock-related hospitalizations in reproductive-aged women (aged 18-45) using the National Inpatient Sample database (years 2016-2021).
Results: Pregnant women with vs without cardiogenic shock had higher rates of cardiovascular comorbidities and were more likely to have preeclampsia (21.3% vs 6.5%), placental hemorrhage (26.6% vs 4.3%), fetal death (10.0% vs 0.51%), and maternal death (17.8% vs 0.01%). Comparing pregnant vs nonpregnant women with cardiogenic shock, pregnant women had lower comorbidity burden and rates of multiorgan failure but higher rates of pulmonary edema (8.9% vs 4.7%). Pregnant women with cardiogenic shock were more likely to undergo extracorporeal membrane oxygenation (adjusted OR: 1.67 [95% CI: 1.07-2.65]) and less likely to die during admission (adjusted OR: 0.43 [95% CI: 0.28-0.66]). Nonpregnant women had higher frequencies of cardiogenic shock from ischemic cardiomyopathy (CM) (25.4% vs 12.4%) and congenital heart disease (5.6% vs 1.8%), while most pregnant women had cardiogenic shock related to nonischemic CM, specifically peripartum CM (30.8%).
Conclusions: There are differences in cardiogenic shock etiology, comorbidities, and clinical complications among pregnant vs nonpregnant women. Findings suggest that unique pregnancy-specific factors may contribute to cardiogenic shock in pregnancy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jacadv.2025.101963 | DOI Listing |
Eur Heart J
September 2025
Medizinische Klinik und Poliklinik II, Universitätsklinikum Bonn, Venusberg-Campus 1, Bonn 53127, Germany.
Background And Aims: Fulminant myocarditis (FM) is a complex clinical syndrome characterized by acute myocardial inflammation and cardiogenic shock. Evidence on long-term outcomes, mortality risk factors, and targeted treatment options remains limited.
Methods: This retrospective analysis included consecutive adult patients admitted for FM between January 2012 and November 2022 at 26 European tertiary centres.
South Afr J Crit Care
May 2025
Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Background: Shock, characterised by circulatory hypoperfusion and cellular hypoxia, represents a critical medical condition requiring immediate attention. Despite its significance, there are limited data on shock incidence and outcomes, particularly within the context of Thailand.
Objectives: This retrospective observational study aimed to investigate the incidence, management and outcomes of shock patients admitted to the internal medicine department of Siriraj Hospital, a referral university hospital in Bangkok, Thailand.
Eur Heart J Open
September 2025
Calderdale and Huddersfield NHS Foundation Trust, Acre St, Lindley, Huddersfield HD3 3EA, UK.
Aims: Cardiogenic shock remains a significant cause of mortality despite multiple advancements in medical interventions. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) provides crucial circulatory support but also increases left ventricular (LV) after-load, potentially worsening outcomes. Effective LV unloading strategies can enhance patient survival during VA-ECMO treatment.
View Article and Find Full Text PDFRev Cardiovasc Med
August 2025
Department of Neurosciences, Institute of Human Anatomy, University of Padova, 35121 Padova, Italy.
Harlequin syndrome, also known as differential hypoxia (DH) or North-South syndrome, is a serious complication of femoro-femoral venoarterial extracorporeal membrane oxygenation (V-A ECMO). Moreover, Harlequin syndrome is caused by competing flows between the retrograde oxygenated ECMO output and the anterograde ejection of poorly oxygenated blood from the native heart. In the setting of impaired pulmonary gas exchange, the addition of an Impella device (ECPELLA configuration), although beneficial for ventricular unloading and hemodynamic support, may further exacerbate this competition and precipitate DH.
View Article and Find Full Text PDFClin Res Cardiol
September 2025
Department of (Interventional) Cardiology, Thoraxcenter, Erasmus University Medical Center, Room Rg-628, P.O. Box 2040, 3000 CA, Rotterdam, the Netherlands.
Background: Fractional flow reserve (FFR) for non-culprit lesions (NCLs) in patients with ST-elevation myocardial infarction (STEMI) can be influenced by temporary changes in microvascular resistance. Angiography-derived vessel fractional flow reserve (vFFR) has been tested as a less-invasive alternative.
Aims: The FAST STEMI II study aimed to assess the diagnostic performance of acute-setting vFFR vs.